Sernova Biotherapeutics Inc (FRA:PSH0)

Market Cap	33.43M -31.7%
Revenue (ttm)	n/a
Net Income	-9.74M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,900
Open	0.1000
Previous Close	0.1070
Day's Range	0.1000 - 0.1000
52-Week Range	0.0750 - 0.1500
Beta	n/a
RSI	52.34
Earnings Date	Jan 27, 2026

About Sernova Biotherapeutics

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc ...

• Industry: Biological Products, Except Diagnostic Substances
• CEO: Jonathan M. Rigby
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PSH0

Financial Performance

Financial numbers in CAD